This diabetes drug can bring serious heart risks

This diabetes drug can bring serious heart risks

Rosiglitazone is a medication used to help people with type 2 diabetes manage their blood sugar levels. It belongs to a class of drugs called thiazolidinediones and was once seen as a promising option for improving blood sugar control. However, recent research from the Yale School of Public Health has raised major concerns about its […] The post This diabetes drug can bring serious heart risks appeared first on Knowridge Science Report.

A diabetes drug company and charity are lobbying the Saskatchewan government as Ottawa promises to follow through on pharmacare

A sign for Eli Lilly & Co. sits outside corporate headquarters in Indianapolis in 2017. The company is lobbying in Saskatchewan about federal pharmacare, as is the charity Diabetes Canada. (AP Photo/Darron Cummings, File) Eli Lilly, a major manufacturer, registered to lobby the province’s government about its drugs being publicly listed and reimbursed and about “pan-Canadian pharmaceutical policy and pricing programs and initiatives; health syst…